当前位置: X-MOL 学术Haematologica › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ixazomib, pomalidomide and dexamethasone in relapsed or refractory multiple myeloma characterized with high-risk cytogenetics: the IFM 2014-01 study.
Haematologica ( IF 8.2 ) Pub Date : 2024-11-14 , DOI: 10.3324/haematol.2024.285916
Arthur Bobin,Salomon Manier,Joe De Keizer,Jaydeep K Srimani,Cyrille Hulin,Lionel Karlin,Denis Caillot,Ingrid Lafon,Clara Mariette,Carla Araujo,Bertrand Arnulf,Benoît Bareau,Karim Belhadj,Lofti Benboubker,Thorsten Braun,Claire Calmettes,Olivier Decaux,Mamoun Dib,Hélène Demarquette,Caroline Jacquet,Cécile Sonntag,Sophie Godet,Arnaud Jaccard,Pascal Lenain,Margaret Macro,Valentine Richez-Olivier,Mourad Tiab,Laure Vincent,Hacene Zerazhi,Marie-Odile Pétillon,Sandrine Rollet,Helene Gardeney,Geraldine Durand,Anthony Levy,Cyrille Touzeau,Aurore Perrot,Philippe Moreau,Thierry Facon,Jill Corre,Stephanie Ragot,Herve Avet-Loiseau,Xavier Leleu

Not available.

中文翻译:


伊沙佐米、泊马度胺和地塞米松治疗以高危细胞遗传学为特征的复发或难治性多发性骨髓瘤:IFM 2014-01 研究。


 不可用。
更新日期:2024-11-14
down
wechat
bug